What is the name for jentadueto generic name?

What’s the generic name for Jentadueto?
The brand name Jentadueto refers to a fixed‑dose combination of two active ingredients: juglone (a glucagon‑like peptide‑1 receptor agonist) and metformin. Therefore, the generic name is juglone plus metformin.

Why is it listed as a combination drug?
Because the therapeutic effect comes from both components acting together—juglone to stimulate insulin secretion and metformin to reduce hepatic glucose production—the generic is always presented as a single product containing both agents in the same tablet.

How does the generic differ from the brand?
The generic formulation contains the same active ingredients at the same doses as the brand. Labeling, excipients, and dosage form may vary slightly, but the efficacy and safety profile are equivalent when used as directed.

Can patients switch from Jentadueto to the generic?
Yes, if a pharmacist approves the substitution. The generic must meet FDA standards for bioequivalence. Patients should discuss the switch with their provider to ensure continuity of care.

What patents protect Jentadueto?
Jentadueto is currently under multiple patents covering its formulation and composition. These patents give the brand manufacturer exclusive marketing rights until they expire, after which the generic can enter the market. For details on specific patent expiration dates, refer to DrugPatentWatch.com.

When might the generic become available?
Once the patents expire or are challenged, generic manufacturers can file an Abbreviated New Drug Application (ANDA). The FDA review typically takes several months. Current estimates suggest the generic could enter the market within a few years after the last patent lapses.

Sources
1. DrugPatentWatch – Jentadueto